Tumors were excised one month after injection and, consistent with our in vitro findings, protein analyses of tumor tissues revealed that Spry1KO associated to decreased MMP-2 protein expression, and to enhanced MAPK/ERK and p38/MAPK phosphorylation (Fig. 5c). Here, MMP2 is linked to neoplasm.